Immunological Profile Changes In Patients with Advanced Non-Small Cell Lung Cancer Undergoing Treatment with Checkpoint Inhibitor Monotherapy
Researchers would like to study how certain biomarkers (signs in your genes that show how well your body responds to a treatment for a disease or condition) change before, during, and after your standard of care treatment for your non-small cell lung cancer (NSCLC). The purpose of this study is to better understand how your genes may change over the course of your treatment.
- IRB Number: 1908650279
- Research Study Identifier: TX10584
- Principal Investigator: Nasser Hanna, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required